Data collected for MUC16 mRNA expression in 37 cancer types originating from the Cancer Genome Atlas were analyzed, and MUC16 was frequently found in low-grade glioma (LGG), leading to further research that indicated mutated MUC16 in LGG was associated with a better prognosis overall [24], while in GBM patients, the same mutation resulted in a worse prognosis [24]. Here, MUC16 is linked to glioblastoma.